Vol 12, No 8 (August 30, 2023): Translational Lung Cancer Research

Editorial

T-cell responses to small cell lung cancer: the immune system and the tumor are two sides of the same coin
Bernard A. M. Van der Zeijst
Translational Lung Cancer Research  
2023;
12
(8)
:1658-1660
.

Expert Consensus

International expert consensus on diagnosis and treatment of lung cancer complicated by chronic obstructive pulmonary disease
Chengzhi Zhou, Yinyin Qin, Wei Zhao, Zhenyu Liang, Min Li, Dan Liu, Li Bai, Yahong Chen, Yan Chen, Yuan Cheng, Tianqing Chu, Qian Chu, Haiyi Deng, Yuchao Dong, Wenfeng Fang, Xiuhua Fu, Beili Gao, Yiping Han, Yong He, Qunying Hong, Jie Hu, Yi Hu, Liyan Jiang, Yang Jin, Fen Lan, Qiang Li, Shuben Li, Wen Li, Yaqing Li, Wenhua Liang, Gen Lin, Xinqing Lin, Ming Liu, Xiaofang Liu, Xiaoju Liu, Zhefeng Liu, Tangfeng Lv, Chuanyong Mu, Ming Ouyang, Jianwen Qin, Shengxiang Ren, Huanzhong Shi, Minhua Shi, Chunxia Su, Jin Su, Dejun Sun, Yongchang Sun, Huaping Tang, Huijuan Wang, Kai Wang, Ke Wang, Mengzhao Wang, Qi Wang, Wei Wang, Xiaoping Wang, Yuehong Wang, Zhijie Wang, Zirui Wang, Lin Wu, Di Wu, Baosong Xie, Min Xie, Xiaohong Xie, Zhanhong Xie, Shufeng Xu, Xiaoman Xu, Xia Yang, Yan Yin, Zongyang Yu, Jian Zhang, Jianqing Zhang, Jing Zhang, Xiaoju Zhang, Yingying Zhang, Diansheng Zhong, Qing Zhou, Xiangdong Zhou, Yanbin Zhou, Bo Zhu, Zhengfei Zhu, Chenxi Zou, Nanshan Zhong, Jianxing He, Chunxue Bai, Chengping Hu, Weimin Li, Yong Song, Jianying Zhou, Baohui Han, Janos Varga, Esther Barreiro, Hye Yun Park, Francesco Petrella, Yuichi Saito, Taichiro Goto, Hitoshi Igai, Sara Bravaccini, Michele Zanoni, Piergiorgio Solli, Satoshi Watanabe, Alfonso Fiorelli, Takeo Nakada, Yoshinobu Ichiki, Rossana Berardi, Nikolaos Tsoukalas, Nicolas Girard, Antonio Rossi, Antonio Passaro, Toyoaki Hida, Shiyue Li, Liang’an Chen, Rongchang Chen
Translational Lung Cancer Research  
2023;
12
(8)
:1661-1701
.

Original Article

Impact of ramucirumab plus erlotinib on circulating cell-free DNA from patients with untreated metastatic non-small cell lung cancer with EGFR-activating mutations (RELAY phase 3 randomized study)
Kazuto Nishio, Kazuko Sakai, Makoto Nishio, Takashi Seto, Carla Visseren-Grul, Michelle Carlsen, Tomoko Matsui, Sotaro Enatsu, Kazuhiko Nakagawa
Translational Lung Cancer Research  
2023;
12
(8)
:1702-1716
.
The effectiveness of surgical treatment of lung cancer in Polish academic and nonacademic centers
Marcin Zbytniewski, Grzegorz M. Gryszko, Marcin M. Cackowski, Anna W. Sienkiewicz-Ulita, Katarzyna Woźnica, Michał Dziedzic, Tadeusz M. Orłowski, Dariusz A. Dziedzic; on behalf of the Polish Lung Cancer Study Group (PLCSG)
Translational Lung Cancer Research  
2023;
12
(8)
:1717-1727
.
Augmented reality navigation-guided intraoperative pulmonary nodule localization: a pilot study
Chengqiang Li, Anqi Ji, Zheng Jian, Yuyan Zheng, Xijia Feng, Wei Guo, Toni Lerut, Jules Lin, Hecheng Li
Translational Lung Cancer Research  
2023;
12
(8)
:1728-1737
.
KMT2C expression and DNA homologous recombination repair factors in lung cancers with a high-grade fetal adenocarcinoma component
Masaki Suzuki, Rika Kasajima, Tomoyuki Yokose, Eigo Shimizu, Seira Hatakeyama, Kiyoshi Yamaguchi, Kazuaki Yokoyama, Kotoe Katayama, Rui Yamaguchi, Yoichi Furukawa, Satoru Miyano, Seiya Imoto, Aya Shinozaki-Ushiku, Tetsuo Ushiku, Yohei Miyagi
Translational Lung Cancer Research  
2023;
12
(8)
:1738-1751
.
Patterns and outcome of unplanned care in lung cancer patients: an observational study in a medical oncology department
Juan C. Sánchez, Beatriz Nuñez-García, Alberto Ruano-Ravina, Mariola Blanco, Arturo Ramos Martín-Vegue, Ana Royuela, Blanca Cantos, Miriam Méndez, Virginia Calvo, Mariano Provencio
Translational Lung Cancer Research  
2023;
12
(8)
:1752-1765
.
Construction and validation of a novel ferroptosis-related prognostic signature for lung adenocarcinoma
Li Yang, Xinxin Fan, Chao Zhou, Ziqi Wang, Zelong Cui, Xuan Wu, Zhiwei Xu, Jia Yang, Xiaoju Zhang
Translational Lung Cancer Research  
2023;
12
(8)
:1766-1781
.
Cost-effectiveness analysis of anlotinib as a third-line or further treatment for advanced non-small cell lung cancer in China
Qiuyan Zhu, Ronghua Ni, Xin Guan
Translational Lung Cancer Research  
2023;
12
(8)
:1782-1789
.
A CT-based radiomics integrated model for discriminating pulmonary cryptococcosis granuloma from lung adenocarcinoma—a diagnostic test
Bin Hu, Wei Xia, Sirong Piao, Ji Xiong, Ying Tang, Hong Yu, Guangyu Tao, Linlin Sun, Minhui Shen, Ajay Wagh, Timothy J. Jaykel, Ding Zhang, Yuxin Li, Li Zhu
Translational Lung Cancer Research  
2023;
12
(8)
:1790-1801
.

Editorial Commentary

Improved understanding of NSCLC immunotherapy response mechanisms from single-cell analysis
Kamila Justyna Bienkowska, Christopher Jon Hanley
Translational Lung Cancer Research  
2023;
12
(8)
:1807-1811
.
Building on success: key takeaways from the 5-year update of the KEYNOTE-407 study
Igor Gómez-Randulfe, Raffaele Califano
Translational Lung Cancer Research  
2023;
12
(8)
:1812-1815
.
Single-cell insights into the dynamic tumor microenvironment changes during immunotherapy of non-small cell lung cancer
Karolina Hanna Prazanowska, Jiwon Hong, Su Bin Lim
Translational Lung Cancer Research  
2023;
12
(8)
:1816-1821
.
Anaplastic lymphoma kinase inhibitor development: enhanced delivery to the central nervous system
Toyoaki Hida
Translational Lung Cancer Research  
2023;
12
(8)
:1822-1825
.
Telisotuzumab vedotin with erlotinib in the treatment of non-small cell lung cancer: a well MET combination?
Lara Kujtan, Janakiraman Subramanian
Translational Lung Cancer Research  
2023;
12
(8)
:1826-1829
.
KEYNOTE-407: an effective and safe first-line treatment option for metastatic squamous non-small cell lung cancer
Hao Chen, Kentaro Yumoto, Fumihiro Kashizaki, Harumi Koizumi, Ichiro Ikeda, Nobuyuki Horita, Kenichi Takahashi, Takeshi Kaneko
Translational Lung Cancer Research  
2023;
12
(8)
:1830-1833
.